Regulation of gene expression by activation of the peroxisome proliferator-activated receptor γ with rosiglitazone (BRL 49653) in human adipocytes

被引:115
作者
Rieusset, J
Auwerx, J
Vidal, H
机构
[1] Univ Lyon 1, INSERM U449, Fac Med Rene Laennec, F-69372 Lyon 08, France
[2] Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch, France
关键词
D O I
10.1006/bbrc.1999.1657
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To better define the mechanism of action of the thiazolidinediones, we incubated freshly isolated human adipocytes with rosiglitazone and investigated the changes in mRNA expression of genes encoding key proteins of adipose tissue functions. Rosiglitazone (10(-6) M, 4 h) increased p85 alpha phosphatidylinositol 3-kinase (p85 alpha PI-3K) and uncoupling protein-2 mRNA levels and decreased leptin. expression. The mRNA levels of insulin receptor, IRS-1, Glut 4, lipoprotein lipase, hormone-sensitive lipase, acylation-stimulating protein, fatty acid transport protein-1, angiotensinogen, plasminogen activator inhibitor-1, and PPAR gamma 1 and gamma 2 were not modified by rosiglitazone treatment. Activation of RXR, the partner of PPAR gamma, in the presence of rosiglitazone, increased. further p85 alpha PI-3K and UCP2 mRNA levels and produced a significant augmentation of Glut 4 expression. Because p85 alpha PI-3K is a major component of insulin action, the induction of its expression might explain, at least in part, the insulin-sensitizing effect of the thiazolidinediones. (C) 1999 Academic Press.
引用
收藏
页码:265 / 271
页数:7
相关论文
共 55 条
[21]   Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat [J].
Hallakou, S ;
Doare, L ;
Foufelle, F ;
Kergoat, M ;
GuerreMillo, M ;
Berthault, MF ;
Dugail, I ;
Morin, J ;
Auwerx, J ;
Ferre, P .
DIABETES, 1997, 46 (09) :1393-1399
[22]   DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements - Importance of the 5'-flanking region [J].
JugeAubry, C ;
Pernin, A ;
Favez, T ;
Burger, AG ;
Wahli, W ;
Meier, CA ;
Desvergne, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (40) :25252-25259
[23]   Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes [J].
Kallen, CB ;
Lazar, MA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (12) :5793-5796
[24]   Thiazolidinediones down-regulate plasminogen activator inhibitor type 1 expression in human vascular endothelial cells:: A possible role for PPARγ in endothelial function [J].
Kato, K ;
Satoh, H ;
Endo, Y ;
Yamada, D ;
Midorikawa, S ;
Sato, W ;
Mizuno, K ;
Fujita, T ;
Tsukamoto, K ;
Watanabe, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 258 (02) :431-435
[25]   CONVERGENCE OF 9-CIS RETINOIC ACID AND PEROXISOME PROLIFERATOR SIGNALING PATHWAYS THROUGH HETERODIMER FORMATION OF THEIR RECEPTORS [J].
KLIEWER, SA ;
UMESONO, K ;
NOONAN, DJ ;
HEYMAN, RA ;
EVANS, RM .
NATURE, 1992, 358 (6389) :771-774
[26]   Thiazolidinediones downregulate stearoyl-CoA desaturase 1 gene expression in 3T3-L1 adipocytes [J].
Kurebayashi, S ;
Hirose, T ;
Miyashita, Y ;
Kasayama, S ;
Kishimoto, T .
DIABETES, 1997, 46 (12) :2115-2118
[27]   Acute regulation by insulin of phosphatidylinositol-3-kinase, Rad, Glut 4, and lipoprotein lipase mRNA levels in human muscle [J].
Laville, M ;
Auboeuf, D ;
Khalfallah, Y ;
Vega, N ;
Riou, JP ;
Vidal, H .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (01) :43-49
[28]   AN ANTIDIABETIC THIAZOLIDINEDIONE IS A HIGH-AFFINITY LIGAND FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA(PPAR-GAMMA) [J].
LEHMANN, JM ;
MOORE, LB ;
SMITHOLIVER, TA ;
WILKISON, WO ;
WILLSON, TM ;
KLIEWER, SA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (22) :12953-12956
[29]   Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPAR alpha and PPAR gamma activators [J].
Martin, G ;
Schoonjans, K ;
Lefebvre, AM ;
Staels, B ;
Auwerx, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (45) :28210-28217
[30]   PPARγ activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression -: PPARγ as a potential mediator in vascular disease [J].
Marx, N ;
Bourcier, T ;
Sukhova, GK ;
Libby, P ;
Plutzky, J .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (03) :546-551